Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07481344 · ClinicalTrials.gov registry record · NA
SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT07481344: Clinical Trial NA study, sponsored by University of Michigan Rogel Cancer Center.
NCT07481344 is a NA study that has not yet begun recruiting, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07481344, a NA study, has not yet begun recruiting, sponsored by University of Michigan Rogel Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Participants will be randomly assigned to either the intervention or control group using concealed allocation. The intervention-comprising targeted educational materials and behavioral prompts-will be delivered over three months preceding race day. All study participants will be required to complete the pre-race survey prior to the intervention. The intervention group will complete the SunBeast Educational module once and receive monthly reinforcement messages leading into race day. The SunBeast Educational Program module consists of a 30-minute live, interactive online discussion and infographics/videos on skin cancer, UV index awareness, sunscreen use, protective clothing, and timing of runs. The control group will receive a general wellness brochure via email. The general wellness brochure will contain UV protection information but will also have other general wellness topics.
Primary Outcome
A lower SEPI score indicates lower risk behavior and higher use of sun protective measures.
Interventions
- OTHER Control
- OTHER SunBeast Educational module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2027-05 |
| Est. Completion | 2027-05 |
| Phase | NA |
What is known before NCT07481344 opens enrollment
NCT07481344 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07481344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07481344 about?
NCT07481344 is a clinical study titled "SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners". Participants will be randomly assigned to either the intervention or control group using concealed allocation. The intervention-comprising targeted educational materials and behavioral prompts-will be delivered over three months preceding race day. All study participants will be required to complet...
What is the current status of trial NCT07481344?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2027-05. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07481344?
The interventions under investigation include: Control (OTHER), SunBeast Educational module (OTHER).
Who is sponsoring clinical trial NCT07481344?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07481344's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia